In monitoring chronic opioid therapy, which process determines the frequency of urine drug testing, database checks, and consideration of dose limits?

• A. Diet
• B. Age
• C. Insurance type
• D. Risk stratification

Answer: (D)

Risk stratification uses a patient’s risk factors to tailor how closely you monitor chronic opioid therapy. By assessing elements such as history of substance use, mental health issues, concurrent sedating medications, prior aberrant behaviors, current opioid dose (MME), and overall stability, clinicians categorize patients into risk levels (high, moderate, low). This categorization then guides how often you perform urine drug tests, how frequently you check the prescription monitoring database, and when you apply dose limits or adjust the monitoring plan. Higher-risk patients warrant more frequent testing and closer oversight, while lower-risk patients require fewer, less intensive checks.

Diet, age, or insurance type don’t reliably predict misuse risk or overdose risk and therefore don’t determine monitoring frequency in the same way risk stratification does.